Table of Contents
Introduction: Understanding the Buzz Around Semaglutide and Jardiance
Over the past few years, the names semaglutide and Jardiance have appeared more often in conversations about diabetes, weight loss, and heart health. These medications are not new, but they have gained attention as more research shows how helpful they can be for people with type 2 diabetes and even those without diabetes but struggling with weight. With more people affected by high blood sugar and obesity around the world, doctors are looking for treatments that do more than just lower glucose. Semaglutide and Jardiance are two medicines that seem to offer more than basic blood sugar control.
Diabetes and obesity are often connected. When blood sugar stays high for a long time, the body becomes resistant to insulin, which makes it harder to control weight. On the other hand, extra body fat can lead to insulin resistance. This cycle makes it very difficult for people to manage their health. Type 2 diabetes, in particular, affects millions and is often linked to lifestyle, but not always. Many people try diet and exercise but still need help from medications. Traditional treatments have focused mostly on bringing blood sugar down, but newer options like semaglutide and Jardiance are changing the way doctors treat this condition. These drugs also help with weight loss, heart health, and kidney protection in certain cases.
Semaglutide and Jardiance belong to newer classes of medicines that target different parts of the body. Semaglutide works on the gut and pancreas. It helps the body release insulin when needed and slows down how fast food leaves the stomach. Jardiance works on the kidneys. It helps remove extra sugar through urine. Because of how they work, these medications have effects beyond lowering blood sugar. They can also help people lose weight, reduce blood pressure, and lower the risk of heart problems in people with type 2 diabetes.
Doctors are using these medications more often, and for good reason. Clinical trials have shown that semaglutide can lead to large weight loss, sometimes similar to the results seen with weight loss surgery. Jardiance has been shown to lower the risk of heart attacks, strokes, and even heart failure in people with diabetes. For these reasons, more people are asking questions about how these medications work, what side effects they might have, and whether they are safe to take long term.
Another reason these medications are so widely discussed is that they come in different forms and can be used for different reasons. Semaglutide is sold under the names Ozempic and Wegovy. Ozempic is used for type 2 diabetes, while Wegovy is approved for weight loss in people with or without diabetes. Jardiance is approved for type 2 diabetes and for reducing the risk of heart failure. It is often used together with other medications like metformin or insulin, and sometimes it is used on its own.
As more people consider using semaglutide or Jardiance, it’s important to understand exactly what they do. There are many articles online and opinions from users, but not all of them are clear or based on science. Some information can even be misleading. A careful look at research studies, side effects, how the medications are taken, and what to expect can help people make better decisions about their health. This is not just about weight or sugar—these medications are part of a much larger picture in treating chronic health conditions.
Learning more about semaglutide and Jardiance can help people see how these medicines fit into modern treatment plans. They are not magic pills, and they come with risks, but they may offer new hope for those who have struggled with their health for years. With more people searching online about how they work, what to expect, and if they are right for them, it’s important to have answers that are easy to understand and based on medical facts.
What Are Semaglutide and Jardiance?
Semaglutide and Jardiance are prescription medicines used to treat type 2 diabetes. They also help with other health problems that often come with diabetes, like being overweight or having a high risk of heart and kidney disease. These two medications work in different ways and belong to different drug classes, but both help control blood sugar levels and offer other important health benefits.
What Is Semaglutide?
Semaglutide is part of a group of drugs called GLP-1 receptor agonists. GLP-1 stands for glucagon-like peptide-1. This is a hormone that the body makes naturally. It helps control blood sugar levels by increasing insulin, lowering the amount of sugar made by the liver, and slowing down digestion so that sugar is absorbed more slowly.
Semaglutide copies the action of the GLP-1 hormone. It helps the pancreas release insulin only when blood sugar is high. It also lowers how much sugar the liver makes and slows how quickly food leaves the stomach. This helps people feel full longer and may lead to weight loss. Because of these effects, semaglutide is used not only for diabetes but also for managing obesity.
There are different brand names for semaglutide, depending on what it is being used to treat:
- Ozempic: Used for adults with type 2 diabetes to lower blood sugar and reduce the risk of heart problems like heart attack or stroke.
- Wegovy: Used for long-term weight management in adults with obesity or who are overweight with certain health problems.
- Rybelsus: A tablet form of semaglutide used for diabetes, taken by mouth instead of injection.
These medicines are usually taken once a week by injection, except for Rybelsus, which is taken daily by mouth. Semaglutide is not used to treat type 1 diabetes and is not for use in people with diabetic ketoacidosis.
What Is Jardiance?
Jardiance is the brand name for empagliflozin, a drug that belongs to a group called SGLT2 inhibitors. SGLT2 stands for sodium-glucose co-transporter 2. This is a protein in the kidneys that helps the body reabsorb glucose (sugar) from urine back into the blood.
Jardiance works by blocking this protein. This means the kidneys remove more sugar through urine instead of keeping it in the body. As a result, blood sugar levels go down. This process also helps lower blood pressure and may lead to a small amount of weight loss.
Jardiance is taken once a day by mouth and is used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes. It is also approved to lower the risk of death from heart disease in adults who have both type 2 diabetes and heart problems. In addition, Jardiance is used to treat heart failure and may help protect kidney function in people at risk for kidney damage.
Jardiance is not for treating type 1 diabetes or diabetic ketoacidosis. It is also not recommended for people with severe kidney disease or those on dialysis.
Key Differences Between Semaglutide and Jardiance
While both medications are used to manage type 2 diabetes and reduce related health risks, they work in different ways and offer different kinds of support:
- Semaglutide acts mainly through hormones and affects the pancreas, stomach, and brain. It helps with insulin release, slows digestion, and can lead to significant weight loss.
- Jardiance works through the kidneys by helping the body get rid of excess sugar through urine. It also lowers blood pressure and supports heart and kidney health.
Both drugs are often used alongside other diabetes medications, such as metformin or insulin, depending on a person’s needs. They are not the same and are not interchangeable, but doctors may use them together in some cases to get better results.
Knowing the differences between semaglutide and Jardiance can help people understand how their diabetes treatment works and why a doctor might choose one over the other. Each medicine plays a special role in managing blood sugar and improving overall health in people with type 2 diabetes.
How Do Semaglutide and Jardiance Work in the Body?
Semaglutide and Jardiance are two different types of medicines, but both help people with type 2 diabetes and weight problems. They work in the body in different ways. Understanding how they work can help explain why they lower blood sugar, help with weight loss, and protect the heart and kidneys.
Semaglutide: Acting Like a Natural Hormone
Semaglutide is part of a group of drugs called GLP-1 receptor agonists. GLP-1 stands for “glucagon-like peptide-1.” This is a hormone that the body makes naturally in the gut after eating. It plays a big role in helping control blood sugar levels.
Semaglutide works by copying the actions of the natural GLP-1 hormone. When this medicine enters the body, it connects to GLP-1 receptors in several areas, such as the pancreas, brain, and stomach. This leads to a few helpful effects:
- Increases insulin release: When blood sugar is high after meals, semaglutide helps the pancreas release more insulin. Insulin is the hormone that helps move sugar from the blood into the body’s cells to be used for energy.
- Lowers glucagon levels: Semaglutide also lowers the amount of glucagon made by the pancreas. Glucagon is another hormone that raises blood sugar, so lowering it helps keep sugar levels steady.
- Slows stomach emptying: This medicine slows down how fast food leaves the stomach. This means sugar enters the blood more slowly after eating, which helps avoid sudden sugar spikes.
- Reduces appetite: Semaglutide also works in the brain to reduce hunger. This makes people feel full faster and may help with eating less, leading to weight loss.
Because of these effects, semaglutide is used not just to treat type 2 diabetes, but also to help with weight loss in people with obesity, even if they do not have diabetes.
Jardiance: Helping the Kidneys Get Rid of Sugar
Jardiance belongs to a different group of drugs called SGLT2 inhibitors. SGLT2 stands for “sodium-glucose co-transporter 2.” This is a protein found in the kidneys that plays a big role in how the body handles sugar.
Normally, the kidneys filter the blood and remove waste, but they also reabsorb sugar and return it to the bloodstream. SGLT2 helps with this reabsorption.
Jardiance blocks the action of SGLT2. When this happens:
- More sugar is passed out in the urine: Instead of reabsorbing sugar, the kidneys let more of it leave the body through the urine. This lowers blood sugar levels without needing insulin.
- Less sugar in the blood: By getting rid of extra sugar through urine, Jardiance helps lower overall blood sugar in people with type 2 diabetes.
- Extra calories are lost: When sugar is removed in the urine, the body loses some calories, which can help with weight loss over time.
- Water is also lost: Sugar pulls water with it, so Jardiance can cause more urine to be made. This can slightly lower blood pressure and may help people with heart problems.
Different Actions, Similar Goals
Although semaglutide and Jardiance work in very different ways—one mimics a gut hormone and works in the brain, pancreas, and stomach, while the other changes how the kidneys filter sugar—they both lead to lower blood sugar, weight loss, and other benefits. These different methods can sometimes work well together in the same patient, helping control blood sugar from multiple directions.
Semaglutide acts more strongly on hunger and digestion, while Jardiance focuses on helping the kidneys remove sugar from the body. Both medications also show benefits for heart and kidney health in large medical studies, even beyond blood sugar control.
Together or alone, these medicines change how the body handles sugar, appetite, and weight, making them useful tools in managing type 2 diabetes and related conditions.
Who Should Take Semaglutide or Jardiance?
Semaglutide and Jardiance are prescription medicines used to treat certain health problems, mostly related to type 2 diabetes and weight. Doctors use specific guidelines to decide who should take these drugs. Not every person with diabetes or weight issues will need them. The choice depends on the person’s overall health, medical history, and treatment goals.
Semaglutide: Approved Uses and Candidates
Semaglutide belongs to a group of drugs called GLP-1 receptor agonists. It is sold under different brand names, including Ozempic, Wegovy, and Rybelsus. Each brand has a slightly different use.
- Ozempic is approved for adults with type 2 diabetes to help lower blood sugar and reduce the risk of major heart problems, such as heart attacks and strokes.
- Rybelsus is an oral version of semaglutide. It is also used to improve blood sugar control in adults with type 2 diabetes.
- Wegovy is approved for weight loss in adults and some teens who are overweight or have obesity. It is meant for those who also have other health problems such as high blood pressure, type 2 diabetes, or high cholesterol.
Semaglutide is not for people with type 1 diabetes. It is also not meant for people with multiple endocrine neoplasia syndrome type 2 (MEN 2) or a family history of medullary thyroid cancer, because of a possible risk of thyroid tumors. People with a history of pancreatitis may need to avoid it, or use it only with close monitoring.
Doctors may suggest semaglutide for adults who:
- Have type 2 diabetes and need better blood sugar control
- Have diabetes and are at high risk for heart disease
- Are overweight (BMI ≥27) and have at least one weight-related health problem
- Have obesity (BMI ≥30), with or without diabetes
The decision is usually made after trying lifestyle changes like healthy eating and exercise. If those steps do not work well enough, semaglutide may be added.
Jardiance: Approved Uses and Candidates
Jardiance (empagliflozin) is part of a group of drugs called SGLT2 inhibitors. It works by helping the kidneys remove sugar from the blood through urine.
Jardiance is approved for adults with:
- Type 2 diabetes, to lower blood sugar and reduce the risk of heart and kidney problems
- Heart failure, with or without diabetes, to lower the risk of death and hospital visits
- Chronic kidney disease, in certain cases, to protect kidney function
It is not for people with type 1 diabetes because it can increase the risk of diabetic ketoacidosis (a serious condition). People with frequent urinary tract infections or those with severe kidney problems may also need to avoid it.
Doctors may recommend Jardiance for people who:
- Have type 2 diabetes and need help controlling blood sugar
- Have diabetes and a history of heart disease or risk factors for heart failure
- Have heart failure, even without diabetes
- Have chronic kidney disease, especially if they are at risk of worsening kidney function
Jardiance is often chosen when a person needs more than just blood sugar control. It helps protect the heart and kidneys, which is very important in people with diabetes who are more likely to develop these problems.
How Doctors Decide
Before starting either drug, doctors look at several factors:
- Blood sugar levels (such as A1C)
- Weight or body mass index (BMI)
- Heart health – whether the person has had heart attacks, heart failure, or stroke
- Kidney function – measured by blood and urine tests
- Other medicines the person takes
- Tolerability – whether the person can manage possible side effects
For people with both diabetes and heart or kidney issues, Jardiance may be a better fit. For those with obesity or who need significant weight loss, semaglutide may be more helpful. Some people may even be prescribed both drugs together, depending on their needs and doctor’s advice.
The goal of using these drugs is to manage diabetes better, lower health risks, and improve quality of life. However, they are not the first step. Diet, physical activity, and other medicines are usually tried first. Semaglutide and Jardiance are added when more help is needed.
What Are the Proven Benefits of Semaglutide and Jardiance?
Semaglutide and Jardiance are two different types of medicines used to treat type 2 diabetes. They have also shown other benefits, such as helping with weight loss and lowering the risk of heart and kidney problems. These effects have been proven in clinical studies with thousands of people. Each medicine works in its own way, but both aim to improve blood sugar control and overall health.
Better Blood Sugar Control
One of the most important goals in managing type 2 diabetes is to keep blood sugar levels in a healthy range. Both semaglutide and Jardiance help lower blood sugar, but they do it differently.
Semaglutide works by acting like a natural hormone in the body called GLP-1. This hormone helps the pancreas release insulin when blood sugar is high. It also slows down how quickly food leaves the stomach, which can keep blood sugar levels from rising too fast after eating. Studies have shown that semaglutide can lower HbA1c (a measure of average blood sugar over the past three months) by 1.0% to 1.5%, depending on the dose and whether the person also takes other diabetes medicines.
Jardiance works in the kidneys. It blocks a protein called SGLT2, which usually helps the body hold on to sugar. When Jardiance blocks this protein, extra sugar is removed from the blood through urine. Jardiance can lower HbA1c by about 0.7% to 1.0%. While the number may seem smaller than semaglutide, the way it works is helpful when used together with other medicines.
Weight Loss Effects
Weight loss is another benefit, especially for people who have both type 2 diabetes and obesity. Semaglutide has a stronger effect on weight than Jardiance.
Semaglutide helps people feel full faster and stay full longer, which leads to eating less. Clinical trials have shown that people taking semaglutide can lose between 5% and 15% of their body weight. In some cases, people without diabetes lost even more. For example, in the STEP trials, people using semaglutide for obesity lost an average of about 15% of their weight over 68 weeks. Weight loss like this can improve blood pressure, cholesterol, and blood sugar levels.
Jardiance also helps with some weight loss, but not as much. It can lead to a loss of 2 to 3 kilograms (about 4 to 7 pounds) in many patients. This happens mostly because the body is getting rid of sugar and calories through the urine. While this is a smaller amount of weight loss, it still supports better blood sugar control and heart health.
Heart Protection
People with type 2 diabetes often have a higher risk of heart disease. This includes problems like heart attacks, heart failure, and strokes. Both semaglutide and Jardiance have been studied for their effects on the heart, and both have shown positive results.
Jardiance was studied in the EMPA-REG OUTCOME trial. In this large study of over 7,000 people with type 2 diabetes and heart disease, Jardiance reduced the risk of death from heart problems by 38%. It also lowered the chance of being hospitalized for heart failure by 35%. These results were strong enough that Jardiance is now often recommended for people with type 2 diabetes who also have heart disease or are at high risk for it.
Semaglutide has also shown benefits for the heart. In the SUSTAIN-6 trial, semaglutide lowered the risk of heart attack, stroke, or heart-related death by 26%. More recently, in the SELECT trial, semaglutide was tested in people with obesity but without diabetes. It showed that semaglutide reduced the risk of major heart problems even in people without high blood sugar. This suggests that the benefits go beyond just treating diabetes.
Kidney Protection
The kidneys are often damaged in people with long-term diabetes. Protecting kidney function is an important part of treatment. Jardiance has shown strong benefits in this area. It can slow down kidney damage and reduce the chance of kidney failure.
In the EMPA-KIDNEY trial, Jardiance helped lower the risk of worsening kidney disease, end-stage kidney failure, or death from kidney problems. Because of this, Jardiance is often chosen for patients who have early signs of kidney problems.
Semaglutide also shows some signs of helping the kidneys, although more research is still being done. Some studies suggest it may reduce protein in the urine, which is a sign of kidney stress. This could mean it helps protect the kidneys over time.
Both semaglutide and Jardiance offer important benefits for people with type 2 diabetes. Semaglutide is especially strong in helping with weight loss and blood sugar control. Jardiance stands out for heart and kidney protection, although it also helps lower blood sugar and leads to some weight loss. Many doctors choose these medications based on a person’s full health picture—whether they need more help with blood sugar, weight, or protection from heart and kidney problems.
How Effective Are They for Weight Loss?
Semaglutide and Jardiance are both medicines used to treat type 2 diabetes. However, they also have effects on body weight. Many people using these drugs notice changes in how much they weigh, especially with semaglutide. Doctors are now prescribing some forms of semaglutide for people who are overweight or have obesity, even if they do not have diabetes.
Semaglutide and Weight Loss
Semaglutide works by acting like a hormone called GLP-1. This hormone is made in the gut and helps control blood sugar levels and hunger. When semaglutide is taken, it helps people feel full sooner and for a longer time. It also slows down how fast food moves through the stomach. This can lead to eating less and losing weight over time.
In clinical studies, people who took semaglutide for weight loss saw big changes in their body weight. In one study called STEP 1, people without diabetes who were overweight or had obesity lost an average of about 15% of their body weight after 68 weeks of using semaglutide along with healthy diet and exercise. That means someone who weighs 220 pounds could lose around 33 pounds.
Other studies also showed that people with type 2 diabetes can lose weight on semaglutide, but the weight loss may be a little less than in people without diabetes. This is likely because diabetes can make weight loss harder, and people with diabetes may also be taking other medications that affect weight.
There are two main brand names of semaglutide: Ozempic and Wegovy. Both contain the same drug, but they are used in different ways. Ozempic is approved to treat type 2 diabetes, while Wegovy is approved to help with weight loss. The dose used for weight loss is usually higher than the dose used for diabetes. Doctors may decide which one to prescribe based on a person’s needs and health conditions.
Jardiance and Weight Changes
Jardiance, also known as empagliflozin, is a different type of medicine. It belongs to a group of drugs called SGLT2 inhibitors. Jardiance works by helping the kidneys get rid of extra sugar in the body through urine. This also causes the body to lose some calories, which can lead to modest weight loss.
On average, people taking Jardiance may lose around 2 to 5 pounds. This amount of weight loss is much smaller compared to what is seen with semaglutide. Still, even small weight changes can be helpful for people with type 2 diabetes, especially when combined with other healthy lifestyle habits.
Jardiance does not affect hunger or fullness like semaglutide. Instead, it leads to weight loss mainly by removing sugar and calories through the urine. This process also causes some water loss, which can show up as a drop in weight, especially in the first few weeks.
Use in People Without Diabetes
Semaglutide is approved under the brand name Wegovy for people who do not have diabetes but are overweight or have obesity. These people must meet certain body weight or body mass index (BMI) criteria and often have at least one weight-related health condition, such as high blood pressure or sleep apnea.
Jardiance, on the other hand, is not approved as a weight loss drug and is not used in people without diabetes for this purpose. Its weight-related effects are considered a secondary benefit, not a main reason to prescribe it.
Importance of Diet and Exercise
Neither semaglutide nor Jardiance works well alone. Healthy eating and regular physical activity are key parts of weight loss and diabetes care. People taking these medicines usually get the best results when they also follow a diet plan and exercise regularly. Doctors often recommend a low-calorie, balanced diet and moderate physical activity, such as walking, swimming, or biking, for at least 150 minutes each week.
In the clinical studies, participants who lost the most weight were also those who stayed on their meal and exercise plans. While the medications can help with hunger or calorie loss, they work best as part of a complete lifestyle plan.
Semaglutide leads to significant weight loss, especially in people without diabetes who take higher doses. It works by controlling appetite and slowing down digestion. Jardiance causes a smaller amount of weight loss by helping the body lose sugar and water. Both medicines can support weight management, but semaglutide is much more effective for this purpose. Diet and exercise are still necessary to get the full benefits of either drug.
What Are the Side Effects and Risks?
All medicines can cause side effects. Semaglutide and Jardiance are helpful drugs, but they can also lead to unwanted problems in some people. Understanding the side effects and knowing the risks helps patients and doctors make safer choices.
Common Side Effects of Semaglutide
Semaglutide is known for helping with weight loss and lowering blood sugar. But many people feel mild side effects when they start taking it. The most common problems are related to the stomach and digestive system.
Some people feel:
- Nausea (a sick feeling in the stomach)
- Vomiting
- Diarrhea
- Constipation
- Stomach pain or bloating
These side effects happen because semaglutide slows down how fast the stomach empties. That is part of how it helps people feel full and eat less. Most of these side effects are not dangerous and usually go away after a few weeks. Starting with a low dose and slowly increasing it helps the body adjust.
However, in some cases, the side effects may last longer or become more severe. If someone keeps vomiting or cannot eat or drink, they may become dehydrated and need to call their doctor.
Serious Risks of Semaglutide
Though less common, semaglutide can lead to serious health problems in some people. These include:
- Pancreatitis: This is swelling of the pancreas. It can cause sudden and severe stomach pain that may spread to the back. This condition needs urgent medical care.
- Gallbladder problems: Some people may develop gallstones or inflammation of the gallbladder. Signs include pain in the upper right side of the belly, fever, and yellowing of the skin or eyes (jaundice).
- Thyroid tumors: In animal studies, semaglutide caused thyroid C-cell tumors. Because of this, it has a boxed warning (the strongest warning from the FDA). People with a history of a rare thyroid cancer called medullary thyroid carcinoma (MTC) or a condition called MEN 2 should not take semaglutide.
- Low blood sugar (hypoglycemia): This is more likely when semaglutide is used with insulin or certain diabetes pills like sulfonylureas. Symptoms include dizziness, shakiness, hunger, and confusion.
Doctors usually monitor people closely when they start semaglutide or change the dose. Blood tests and checkups can help catch problems early.
Common Side Effects of Jardiance
Jardiance works in the kidneys to lower blood sugar by helping the body remove extra glucose through urine. This action can lead to different side effects than semaglutide.
The most common side effects of Jardiance include:
- Urinary tract infections (UTIs): Symptoms include burning during urination, frequent urination, and lower belly pain.
- Yeast infections: Both men and women can get genital yeast infections because of the extra sugar in the urine. These infections cause itching, redness, and discomfort.
These infections are usually mild and can be treated with medicine. Drinking enough water and keeping the genital area clean can help prevent them.
Serious Risks of Jardiance
Jardiance also has some serious but rare side effects that should be watched closely:
- Ketoacidosis: This is a serious condition where the body makes too many acids called ketones. It can happen even when blood sugar is not very high. Symptoms include nausea, vomiting, belly pain, and confusion. Ketoacidosis needs emergency care.
- Dehydration and low blood pressure: Because Jardiance makes the body lose more water through urine, some people may feel dizzy or lightheaded, especially when standing up. This is more likely in older adults or people taking water pills (diuretics).
- Kidney problems: Although Jardiance is used to protect the kidneys in many cases, it can also cause or worsen kidney injury in some people, especially when the body is dehydrated.
- Fournier’s gangrene: This is a very rare but serious infection of the skin and tissues around the genitals. It requires emergency treatment. Signs include fever, pain, redness, and swelling in the genital or anal area.
Who Should Not Use These Medications
Some people should not take semaglutide or Jardiance due to certain health conditions. These include:
- A personal or family history of medullary thyroid cancer (for semaglutide)
- A condition called MEN 2 (for semaglutide)
- People with type 1 diabetes or those who have had diabetic ketoacidosis (for Jardiance)
- People with severe kidney disease or who are on dialysis (for Jardiance)
Pregnant or breastfeeding women should not take semaglutide or Jardiance unless their doctor says it is absolutely necessary.
Monitoring and Safety Tips
Doctors may order blood tests to check the pancreas, kidneys, and thyroid before starting treatment. It is also important to watch for new symptoms and report them quickly.
Taking semaglutide or Jardiance as directed, staying hydrated, and following up with regular check-ups can lower the chance of side effects.
Can Semaglutide or Jardiance Be Taken Together or With Other Medications?
Semaglutide and Jardiance are both commonly prescribed medications for people with type 2 diabetes. They work in different ways, and in many cases, doctors may prescribe them together to help manage blood sugar levels more effectively. These two drugs can also be used alongside other medications. However, combining them with other treatments requires careful planning to avoid problems and ensure safety.
Using Semaglutide and Jardiance Together
Semaglutide and Jardiance can be safely taken together. They belong to different classes of medications, which means they target different parts of the body to lower blood sugar.
Semaglutide is a GLP-1 receptor agonist. It works by helping the pancreas release more insulin when blood sugar is high. It also slows down how fast food leaves the stomach and reduces appetite, which can lead to weight loss.
Jardiance is an SGLT2 inhibitor. It works in the kidneys to stop sugar from being absorbed back into the blood. Instead, the sugar leaves the body through urine.
Because these two drugs work in different ways, using them together can lead to better blood sugar control than using just one. Studies have shown that this combination can also lead to more weight loss and a lower risk of heart and kidney problems. Many diabetes guidelines support this combination, especially for people who need extra help lowering blood sugar or who are overweight or have heart disease.
Combining With Other Diabetes Medications
Semaglutide and Jardiance are often taken with other diabetes drugs like metformin, insulin, or sulfonylureas. Metformin is usually the first drug used for type 2 diabetes. It helps the body use insulin better and lowers how much sugar the liver makes. Both semaglutide and Jardiance can be added to metformin if blood sugar is still too high.
When adding semaglutide or Jardiance to metformin, there is usually no need to change the metformin dose. These drugs work well together and are often found in treatment plans for people with type 2 diabetes.
Insulin can also be used with semaglutide and Jardiance. However, when insulin is added, the risk of low blood sugar (hypoglycemia) increases. Semaglutide and Jardiance do not usually cause low blood sugar on their own, but insulin does. So, when these drugs are combined, the insulin dose may need to be lowered to avoid hypoglycemia.
Sulfonylureas, like glipizide or glyburide, also increase insulin release and can cause low blood sugar. When using these drugs with semaglutide or Jardiance, it’s important to monitor blood sugar levels closely. The dose of the sulfonylurea might need to be adjusted.
Risk of Hypoglycemia and How to Prevent It
One of the most important things to watch for when combining medications is low blood sugar. Semaglutide and Jardiance rarely cause this on their own. However, if they are used with insulin or sulfonylureas, the chance of hypoglycemia goes up.
Symptoms of low blood sugar include sweating, shakiness, confusion, hunger, and dizziness. If blood sugar drops too low, it can be dangerous. To prevent this, doctors often lower the dose of insulin or sulfonylureas when starting semaglutide or Jardiance.
People who take multiple diabetes medications may need to check their blood sugar more often. Keeping track of blood sugar levels can help adjust doses and prevent sudden drops.
Other Medication Interactions
Semaglutide and Jardiance usually do not interact with most other medications. However, semaglutide slows down how fast food and medicine move through the stomach. This can affect how some oral medications are absorbed. For example, if a person takes thyroid medicine or birth control pills, their doctor may want to check if these drugs are still working well after starting semaglutide.
Jardiance, which works through the kidneys, may increase the risk of dehydration, especially when taken with water pills (diuretics). This can lead to low blood pressure, dizziness, or kidney problems. It’s important to stay well-hydrated and to tell the doctor about any other medications being taken.
Coordinating With Healthcare Providers
When using semaglutide, Jardiance, or both, along with other medications, it’s important that all doctors involved in care are aware of the full medication list. Pharmacists can also help check for interactions and make sure all medications are safe to use together.
Doctors may make changes to medication doses over time, based on how well blood sugar is controlled, any side effects, and changes in weight or kidney function. Regular follow-up visits, blood tests, and open communication with healthcare providers help make combination treatment safe and effective.
Using semaglutide and Jardiance together or with other diabetes medications can offer strong benefits, but the treatment plan should always be tailored to each person’s health needs.
What Happens When You Stop Taking Semaglutide or Jardiance?
Stopping medications like semaglutide or Jardiance can cause changes in how the body handles blood sugar and weight. These medicines are often part of a long-term plan to manage type 2 diabetes, help with weight loss, or lower the risk of heart and kidney problems. When these medications are stopped, some of their helpful effects may start to go away. Knowing what to expect can help prevent sudden changes in health.
Blood Sugar Levels May Rise Again
Semaglutide and Jardiance both help lower blood sugar levels. When a person stops taking either of these drugs, their blood sugar can go back up. This is especially true if the person is not using other medications or lifestyle changes to manage diabetes. Without these drugs, the body may return to the same level of insulin resistance or poor glucose control as before.
Semaglutide helps the body make more insulin when needed and slows the movement of food through the stomach. This helps keep blood sugar from spiking after meals. Jardiance works differently. It helps the body get rid of extra sugar through urine. Stopping either drug removes these effects, so blood sugar may rise within days or weeks.
In people with type 2 diabetes, a sudden rise in blood sugar can lead to symptoms such as fatigue, thirst, blurry vision, and frequent urination. If left uncontrolled, high blood sugar may also increase the risk of long-term complications like nerve damage, kidney problems, or eye disease.
Weight May Return
Many people take semaglutide not just for diabetes but also for weight loss. This drug changes hunger signals in the brain and helps people feel full longer. It also slows down how fast the stomach empties. These effects help people eat less and lose weight over time.
When semaglutide is stopped, appetite often returns to the way it was before treatment. Without the drug’s support, it becomes harder to control portion sizes and hunger. As a result, many people regain some or all of the weight they lost. This is sometimes called “rebound weight gain.” Clinical studies have shown that people who stop semaglutide tend to gain back weight unless they follow a strict diet and exercise plan.
Jardiance may also cause a small amount of weight loss, mostly because it helps the body get rid of sugar and calories through the urine. But this effect is much smaller than what is seen with semaglutide. When Jardiance is stopped, the small amount of weight loss may not last.
Risk of Relapse in Diabetes Symptoms
Semaglutide and Jardiance help with more than just blood sugar and weight. They also protect the heart and kidneys. For example, Jardiance has been shown to lower the risk of heart failure and slow down kidney disease in people with type 2 diabetes. Semaglutide can reduce the risk of heart attacks and strokes.
Stopping these drugs may remove those protective effects. The heart and kidneys may face higher risks again. For patients with a history of heart or kidney problems, stopping treatment could lead to worsening symptoms or new health issues.
Some People May Feel Side Effects After Stopping
Most people do not feel any withdrawal symptoms when stopping these medications. They are not addictive, and there are no major physical withdrawal symptoms like those caused by some other drugs. However, some people may notice their appetite increasing, energy dropping, or blood sugar fluctuating. This is not because of the medicine itself leaving the body, but because the condition it was treating is no longer being controlled.
Tapering Off vs. Stopping Suddenly
There is no standard rule for how to stop semaglutide or Jardiance, but doctors usually recommend not stopping suddenly. Depending on the person’s health, it may be safer to slowly reduce the dose or replace the medication with another treatment. This approach helps prevent big changes in blood sugar or weight.
Some people stop semaglutide because of side effects like nausea or vomiting. In those cases, a doctor may suggest switching to a different dose or another type of medication. The same goes for Jardiance, especially if it causes urinary tract infections or dehydration.
Follow-Up Care Is Important
After stopping either medication, regular follow-ups with a healthcare provider are important. Blood sugar should be checked often to make sure it is not going too high. Weight, kidney function, and blood pressure should also be monitored. If problems return, the doctor may suggest restarting the medication or trying a different one.
Healthy lifestyle habits such as eating a balanced diet, staying active, and getting enough sleep become even more important after stopping semaglutide or Jardiance. These habits can help keep weight and blood sugar under control without medication.
Stopping semaglutide or Jardiance can cause blood sugar to rise, weight to return, and protection for the heart and kidneys to fade. These changes do not happen right away for everyone, but they are common. Careful planning, medical guidance, and healthy daily habits can help manage the risks and maintain good health after stopping these medications.
What Do We Know About Long-Term Use?
Semaglutide and Jardiance are both used to treat type 2 diabetes. Semaglutide is also used for weight loss. These medicines have shown strong results in studies lasting several months. But what happens when people use them for a long time—over several years?
Researchers have been studying the long-term effects of these drugs. Most trials lasted one to two years. Some are still going on to track results for five years or longer. What has been learned so far helps doctors and patients understand what to expect.
Long-Term Blood Sugar Control
One key goal of these medicines is to help lower blood sugar. Semaglutide and Jardiance both do this in different ways. In long-term studies, many people kept their blood sugar levels in a healthy range for a year or more. Some studies showed this benefit lasting for up to two years, as long as the medicine was taken regularly.
In trials, semaglutide helped people lower their HbA1c levels (a measure of average blood sugar) by about 1.0% to 1.5%. This reduction often continued as long as people stayed on the medicine. Jardiance showed similar results, with HbA1c reductions of about 0.5% to 0.9%. These numbers may seem small, but even a 1% drop in HbA1c can lower the risk of serious health problems like heart disease, kidney failure, and nerve damage.
Long-Term Weight Loss and Management
Semaglutide is also used to help people lose weight. This version is sold under the brand name Wegovy. Studies that followed patients for up to 68 weeks (a little over a year) showed strong and lasting weight loss. On average, people lost about 15% of their body weight. Some people lost even more.
Even after 68 weeks, many people kept the weight off. This suggests that semaglutide can help with long-term weight control. However, some weight may return if the medicine is stopped. That is why long-term treatment may be needed for people who want to keep the weight off.
Jardiance does not cause large weight loss like semaglutide. But it may help people lose a small amount of weight—usually 2 to 3 pounds. More importantly, it does not cause weight gain, which some diabetes medicines do.
Heart and Kidney Protection Over Time
Both semaglutide and Jardiance help protect the heart and kidneys, especially in people with diabetes who have a high risk of heart disease.
Long-term studies have shown that Jardiance lowers the risk of heart failure, heart attacks, and hospital stays. It also protects kidney function by helping reduce protein in the urine and slowing the loss of kidney filtering ability.
Semaglutide also helps protect the heart. In the SELECT trial, people with obesity but no diabetes had fewer heart problems when taking semaglutide for several years. This suggests that its benefits go beyond just blood sugar or weight loss.
Staying on the Medicine Over Time
One concern with long-term use is whether people can stick with these treatments. Both medicines are taken once a day (Jardiance) or once a week (semaglutide injection). This makes it easier for many people to remember.
However, side effects can make some people stop using them. For semaglutide, stomach problems like nausea and vomiting are common in the beginning. These symptoms often get better over time, but for some people they continue. Jardiance may cause urinary tract infections or dehydration, especially in older adults.
Even with these issues, many people stay on these medicines for months or years. Doctors can help manage side effects by adjusting the dose or giving advice on how to handle symptoms.
What Long-Term Monitoring Is Needed?
Doctors often check blood sugar, kidney function, and weight during treatment. People taking semaglutide may also need to watch for signs of thyroid problems or pancreatitis, although these are rare. Those on Jardiance should be checked for signs of dehydration or yeast infections.
Regular check-ups help make sure the medicine is still working well and is safe to continue.
So far, long-term studies show that semaglutide and Jardiance are both effective and generally safe when used for extended periods. They help manage blood sugar, support weight loss or stability, and lower the risk of heart and kidney problems. Staying on the medicine and getting regular check-ups can help people get the most from these treatments over time.
Are There Cost or Accessibility Barriers?
Semaglutide and Jardiance are powerful medications that help manage type 2 diabetes, reduce heart disease risk, and support weight loss. However, the cost and access to these medications can be a major concern for many people. These drugs are often expensive, and not everyone has health insurance that covers them. Understanding how much they cost, who pays for them, and what help is available can make a big difference in whether people can use them.
Cost of Semaglutide and Jardiance
Semaglutide is sold under brand names like Ozempic (for type 2 diabetes) and Wegovy (for weight loss). Jardiance is the brand name for empagliflozin. None of these drugs are currently available as generics in most places, which means the prices are higher than older medications.
Without insurance, a one-month supply of semaglutide (either Ozempic or Wegovy) can cost around $900 to $1,200. Jardiance is also expensive, with a one-month supply costing around $550 to $650. These prices can vary depending on the pharmacy and the location, but in general, these drugs are much more expensive than common older diabetes medications like metformin.
For many people, this high cost is a barrier. Even those with insurance might face challenges if their plan doesn’t cover these drugs fully. Some insurance plans require a co-pay, which can still be several hundred dollars per month. Others may not cover the drugs at all if they are being used for weight loss instead of diabetes.
Insurance Coverage and Formularies
Health insurance plans often have a list of approved drugs called a formulary. If a medication is not on that list, the insurance company may not pay for it. Semaglutide and Jardiance are usually covered for people who have type 2 diabetes. However, coverage can depend on the specific plan.
When semaglutide is used for weight loss (as Wegovy), some plans do not cover it at all, because many insurance companies do not cover weight loss medications. This includes both private insurance and government programs like Medicare. Medicaid coverage also varies by state. Some states may cover these medications, while others do not.
To get insurance approval, doctors often have to provide proof that the drug is medically necessary. This may include blood sugar results, body mass index (BMI), and a history of other treatments that didn’t work. This process is called “prior authorization” and can delay starting the medication.
Patient Assistance Programs
To help with the high cost, many drug manufacturers offer patient assistance programs. These programs provide discounts or even free medication to people who qualify. The programs usually look at income, insurance status, and whether the person is a U.S. resident.
For example, the maker of Ozempic and Wegovy, Novo Nordisk, has assistance programs for patients with limited income or no insurance. Similarly, Boehringer Ingelheim, the company that makes Jardiance, offers help through its own savings program.
Some of these programs offer discount cards that can reduce the monthly cost of the medicine. Others may give the medicine at no cost for a limited time. Pharmacies and clinics can often help patients find out if they qualify and help them apply.
Global Access and Disparities
Outside the United States, access to semaglutide and Jardiance also varies. In some countries, these drugs are part of national health systems and are more affordable. In others, they may be even more expensive and harder to find.
In low- and middle-income countries, very few people have access to these new medications. Even when they are available, only a small group of patients can afford them. This creates health care inequalities, where people in wealthier countries or with better insurance have more options for managing their health.
While semaglutide and Jardiance offer strong benefits for managing type 2 diabetes and supporting weight loss, their high cost and limited access remain major barriers. Insurance coverage varies, and not everyone can afford these medications out of pocket. Help is available through manufacturer programs and discount cards, but not everyone qualifies. Expanding access to these treatments will be important for ensuring that more people can benefit from them, no matter where they live or what insurance they have.
Conclusion: What These Medications Really Offer in Managing Diabetes and Weight
Semaglutide and Jardiance are two important medications used to treat type 2 diabetes. They help lower blood sugar levels and reduce other health risks linked to diabetes. While both drugs have different ways of working inside the body, each offers strong benefits. These benefits go beyond just managing blood sugar. They also help with weight loss and protect the heart and kidneys in some patients. This is why doctors often choose these medications for people who need more than just basic diabetes treatment.
Semaglutide works by acting like a hormone that the body already makes. This hormone, called GLP-1, helps control blood sugar by increasing insulin when it is needed and lowering the release of another hormone called glucagon. It also slows down how fast the stomach empties food. This makes people feel full longer, which can help them eat less and lose weight. Many patients who take semaglutide lose a significant amount of weight, even those who do not have diabetes. For this reason, the same medicine is sold under a different name, Wegovy, to help people with obesity or who are overweight with related health problems.
Jardiance works in a different way. It helps the kidneys remove extra sugar from the blood by sending it out through urine. This helps lower blood sugar in people with type 2 diabetes. It also has other benefits. Jardiance has been shown to reduce the risk of heart failure and protect kidney function. This is very important because heart and kidney problems are common in people with type 2 diabetes. Studies have shown that Jardiance can help people live longer by lowering the risk of heart-related death.
While both semaglutide and Jardiance help with blood sugar control, they also help in different areas. Semaglutide has stronger effects on weight loss. Jardiance is better known for protecting the heart and kidneys. Because of this, some people may take both medications at the same time. Doctors will choose the right combination based on the person’s health needs, other medications, and possible side effects.
There are also some risks and side effects that must be considered. Semaglutide often causes nausea, vomiting, or stomach pain, especially when starting the medicine. Jardiance can increase the risk of urinary tract infections and yeast infections. Both medications can cause more serious problems in rare cases, such as pancreatitis or diabetic ketoacidosis. These risks are why doctors often monitor patients closely, especially during the first few months of treatment. It is also important for people taking these medications to stay well-hydrated and to report any new symptoms quickly.
When people stop taking semaglutide or Jardiance, blood sugar levels may go back up, and weight might return. This can happen because the medicines are no longer helping the body manage food and sugar in the same way. That is why long-term use is often recommended if the person tolerates the medicine well and sees good results. Long-term studies have shown that both medications can continue to help with blood sugar, weight, and heart health for several years. However, like all long-term treatments, it is important to keep checking that the medicine is still needed and is still working as expected.
Access to these medications is also something to think about. Semaglutide and Jardiance can be expensive. Some health insurance plans may not cover them, or they may only cover part of the cost. Patient assistance programs are available in some cases, but not everyone qualifies. This makes it harder for some people to start or stay on these medications. In other countries outside the United States, the same problems exist with cost and access. These are areas where more help and better policy choices could improve care for people with diabetes and obesity.
Both semaglutide and Jardiance show what modern medicine can do to treat complex health problems. These drugs treat more than just symptoms—they target the root causes of disease and help prevent future problems. They give people with type 2 diabetes more control over their health. While these medicines are not right for everyone, they offer powerful options for those who need them. With careful use and medical guidance, semaglutide and Jardiance can lead to better blood sugar control, weight loss, and lower risk of serious health issues. As research continues, these medicines may become part of even more treatment plans in the future.
Research Citations
Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., … Kushner, R. F. (2021). Once‐weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989–1002.
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., … SUSTAIN‐6 Investigators. (2016). Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. New England Journal of Medicine, 375(19), 1834–1844.
Husain, M., Birkenfeld, A. L., Donsmark, M., Dungan, K., Eliaschewitz, F. G., Franco, D. R., … PIONEER 6 Investigators. (2019). Cardiovascular safety and benefits of oral semaglutide in patients with type 2 diabetes. New England Journal of Medicine, 381(9), 841–851.
Garvey, W. T., Batterham, R. L., Bhatta, M., Apovian, C. M., Bush, M., Day, W. W., … Davies, M. (2022). Two‐year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091.
Sorli, C., Harashima, S. I., Tsoukas, G. M., Unger, J., Karsbøl, J. D., Hansen, T., & Bain, S. C.; SUSTAIN 1 Investigators. (2017). Efficacy and safety of once‐weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): A double‐blind, randomized, placebo‐controlled, parallel‐group, multinational, multicentre, phase 3a trial. Lancet Diabetes & Endocrinology, 5(4), 251–260.
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., … EMPA‐REG OUTCOME Investigators. (2015). Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. New England Journal of Medicine, 373(22), 2117–2128.
Wanner, C., Inzucchi, S. E., Lachin, J. M., Fitchett, D., von Eynatten, M., Mattheus, M., … Zinman, B.; EMPA‐REG OUTCOME Investigators. (2016). Empagliflozin and progression of kidney disease in type 2 diabetes. New England Journal of Medicine, 375(4), 323–334.
Packer, M., Anker, S. D., Butler, J., Filippatos, G., Pocock, S. J., Carson, P., … EMPEROR‐Reduced Trial Investigators. (2020). Cardiovascular and renal outcomes with empagliflozin in heart failure. New England Journal of Medicine, 383(15), 1413–1424.
Herrington, W. G., Ruta, L. M., Takura, T., et al. (2023). Empagliflozin in patients with chronic kidney disease. New England Journal of Medicine, 389(20), 1878–1890.
Zinman, B., Inzucchi, S. E., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., & Wanner, C.; EMPA‐REG OUTCOME Investigators. (2014). Rationale, design, and baseline characteristics of a randomized, placebo‐controlled cardiovascular outcome trial of empagliflozin (EMPA‐REG OUTCOME). Cardiovascular Diabetology, 13, 102.
Questions and Answers: Semaglutide and Jardiance
Semaglutide is used to treat type 2 diabetes and to aid in weight management in people with obesity or overweight conditions.
Jardiance (empagliflozin) belongs to a class of drugs called SGLT2 inhibitors, which lower blood sugar by causing the kidneys to remove glucose from the body through urine.
Semaglutide is typically administered as a once-weekly subcutaneous injection.
Jardiance is not specifically approved for weight loss, but it may cause modest weight reduction as a side effect due to its mechanism of action.
Common side effects include nausea, vomiting, diarrhea, constipation, and decreased appetite.
Serious side effects can include ketoacidosis, urinary tract infections, dehydration, and genital infections.
Yes, Semaglutide can be combined with other diabetes medications, but dose adjustments may be necessary to avoid hypoglycemia.
Jardiance has been shown to reduce the risk of cardiovascular death in patients with type 2 diabetes and established heart disease.
Semaglutide mimics the GLP-1 hormone, which increases feelings of fullness, slows gastric emptying, and reduces appetite.
People with severe kidney problems, those on dialysis, or with a history of ketoacidosis should avoid Jardiance unless advised by a healthcare provider.
Dr. Jay Flottman
Dr. Jay Flottmann is a physician in Panama City, FL. He received his medical degree from University of Texas Medical Branch and has been in practice 21 years. He is experienced in military medicine, an FAA medical examiner, human performance expert, and fighter pilot.
Professionally, I am a medical doctor (M.D. from the University of Texas Medical Branch at Galveston), a fighter pilot (United States Air Force trained – F-15C/F-22/AT-38C), and entrepreneur.